Short Interest in Tema Heart & Health ETF (NASDAQ:HRTS) Rises By 105.7%

Tema Heart & Health ETF (NASDAQ:HRTS) was the recipient of a large increase in short interest in August. As of August 31st, there was short interest totaling 5,158 shares, an increase of 105.7% from the August 15th total of 2,508 shares. Based on an average daily volume of 2,948 shares, the short-interest ratio is presently 1.7 days. Currently, 0.3% of the shares of the stock are sold short.

Institutional Investors Weigh In On Tema Heart & Health ETF

A number of hedge funds have recently modified their holdings of HRTS. Royal Bank of Canada raised its stake in Tema Heart & Health ETF by 8.8% during the first quarter. Royal Bank of Canada now owns 21,083 shares of the company’s stock worth $710,000 after purchasing an additional 1,703 shares during the period. Rothschild Capital Partners LLC acquired a new stake in shares of Tema Heart & Health ETF during the 2nd quarter worth approximately $651,000. Members Advisory Group LLC acquired a new stake in shares of Tema Heart & Health ETF during the 2nd quarter worth approximately $398,000. Anson Capital Inc. purchased a new stake in shares of Tema Heart & Health ETF during the 2nd quarter valued at approximately $297,000. Finally, XML Financial LLC purchased a new stake in shares of Tema Heart & Health ETF during the 2nd quarter valued at approximately $223,000.

Tema Heart & Health ETF Price Performance

NASDAQ HRTS traded down $0.12 during trading hours on Wednesday, reaching $36.37. The company’s stock had a trading volume of 591 shares, compared to its average volume of 5,756. Tema Heart & Health ETF has a 1-year low of $29.54 and a 1-year high of $38.87. The company’s 50-day moving average is $37.10 and its two-hundred day moving average is $35.24. The firm has a market capitalization of $72.70 million, a price-to-earnings ratio of 22.06 and a beta of 0.63.

About Tema Heart & Health ETF

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.